Published in Clin Nephrol on July 01, 1975
Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet (1995) 4.06
Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). J Clin Invest (2001) 2.20
The association of peptic ulceration, chronic renal disease, and analgesic abuse. Q J Med (1966) 2.07
A multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients with hypercholesterolemia. Am J Cardiol (1997) 1.77
Reduced bone mass in daughters of women with osteoporosis. N Engl J Med (1989) 1.70
Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic rat. Diabetes (1991) 1.58
Enalapril retards glomerular basement membrane thickening and albuminuria in the diabetic rat. Diabetologia (1989) 1.57
Superior renoprotective effects of combination therapy with ACE and AGE inhibition in the diabetic spontaneously hypertensive rat. Diabetologia (2003) 1.55
Rapid microbiological assay for 5-fluorocytosine. Br Med J (1973) 1.47
The relative roles of advanced glycation, oxidation and aldose reductase inhibition in the development of experimental diabetic nephropathy in the Sprague-Dawley rat. Diabetologia (1995) 1.46
Neoplasia in patients with chronic renal failure on long-term dialysis. Clin Nephrol (1976) 1.46
Acute hepatic coma treated by cross-circulation or exchange transfusion. N Engl J Med (1967) 1.46
Estimating glomerular filtration rate in diabetes: a comparison of cystatin-C- and creatinine-based methods. Diabetologia (2006) 1.42
Progressive decline in renal function in diabetic patients with and without albuminuria. Diabetes (1994) 1.40
Application of Heyrovsky's inulin method to automatic analysis. Clin Chim Acta (1965) 1.39
Renal protection by angiotensin II receptor antagonists in patients with type 2 diabetes. Med J Aust (2001) 1.39
The use of prindolol (Visken) in the treatment of hypertension. Med J Aust (1972) 1.38
Renal expression of transforming growth factor-beta inducible gene-h3 (beta ig-h3) in normal and diabetic rats. Kidney Int (1998) 1.36
Influence of age on the presentation and outcome of acidotic and hyperosmolar diabetic emergencies. Intern Med J (2002) 1.35
A comparison of guanacline with methyldopa in the treatment of hypertension. Med J Aust (1968) 1.21
Heterologous liver perfusion in acute hepatic failure. Br Med J (1967) 1.20
Methyldopa and haemolytic anaemia. Med J Aust (1967) 1.13
Vascular hypertrophy in experimental diabetes. Role of advanced glycation end products. J Clin Invest (1997) 1.12
Albuminuria in patients with type 1 diabetes is directly linked to changes in the lysosome-mediated degradation of albumin during renal passage. Diabetes (2000) 1.09
The accuracy of cystatin C and commonly used creatinine-based methods for detecting moderate and mild chronic kidney disease in diabetes. Diabet Med (2007) 1.08
Effect of thyroid status on ouabain binding to the human lymphocyte. J Clin Endocrinol Metab (1982) 1.06
Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes. Diabetologia (2000) 1.03
Prevention of albuminuria by aminoguanidine or ramipril in streptozotocin-induced diabetic rats is associated with the normalization of glomerular protein kinase C. Diabetes (2000) 1.03
A comparison of chlorothiazide, chlorthalidone and cyclopenthiazide in the treatment of hypertension. Med J Aust (1973) 1.02
Plasma levels and urinary excretion of nalidixic acid in patients with renal failure. Aust N Z J Med (1971) 0.99
Direct biochemical demonstration of two types of alpha-adrenoreceptor in rat brain. Nature (1978) 0.99
Acute silicoproteinosis. Thorax (1977) 0.99
Anaplastic transitional-cell carcinoma of the renal pelvis in association with analgesic abuse. Med J Aust (1970) 0.98
Rupture of diaphragm associated with spinal cord injury. Aust N Z J Surg (1981) 0.97
Minocycline excretion and distribution in relation to renal function in man. Clin Exp Pharmacol Physiol (1975) 0.97
Renal hyperfiltration in type 2 diabetes: effect of age-related decline in glomerular filtration rate. Diabetologia (2005) 0.97
Clinical, biochemical and histological observations on the effect of porcine calcitonin in Paget's disease of bone. Aust N Z J Med (1977) 0.97
Patterns of glycaemic control in Australian primary care (NEFRON 8). Intern Med J (2008) 0.97
Renoprotective effects of a novel inhibitor of advanced glycation. Diabetologia (2001) 0.97
Microalbuminuria: prognostic and therapeutic implications in diabetes mellitus. Diabet Med (1994) 0.96
Effects of insulin on body composition in patients with insulin-dependent and non-insulin-dependent diabetes. Diabet Med (1996) 0.96
Increased epidermal growth factor in experimental diabetes related kidney growth in rats. Diabetologia (1997) 0.95
Reuse of a disposable dialyser for home dialysis. Med J Aust (1976) 0.95
Vagotomy for gastric ulcer combined with duodenal ulcer. Br J Surg (1971) 0.95
Clinical staging for cutaneous T-cell lymphoma. Ann Intern Med (1984) 0.95
Long-term efficacy and tolerability of simvastatin in a large cohort of elderly hypercholesterolemic patients. Atherosclerosis (1995) 0.94
Effects of genetic hypertension on diabetic nephropathy in the rat--functional and structural characteristics. J Hypertens (1988) 0.94
Benign fibrous histiocytoma of bone. Am J Surg Pathol (1985) 0.94
Plasma renin levels and vascular complications in hypertension. Br Med J (1973) 0.94
Gelatinous transformation of the bone marrow. Pathology (1983) 0.94
The pharmacokinetics of captopril and captopril disulfide conjugates in uraemic patients on maintenance dialysis: comparison with patients with normal renal function. Eur J Clin Pharmacol (1987) 0.93
Inflammation, hepatic enzymes and resistance training in individuals with metabolic risk factors. Diabet Med (2009) 0.92
Early nephropathy predicts vision-threatening retinal disease in patients with type I diabetes mellitus. J Am Soc Nephrol (1998) 0.92
Expression of transforming growth factor-beta1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: effects of ACE inhibition. Diabetes (1998) 0.91
Pharmacokinetic properties of captopril after acute and chronic administration to hypertensive subjects. Am J Cardiol (1982) 0.91
Treatment of dialysis osteomalacia with desferrioxamine. Lancet (1982) 0.91
Salt supplementation blunts the blood pressure response to telmisartan with or without hydrochlorothiazide in hypertensive patients with type 2 diabetes. Diabetologia (2010) 0.91
The effect of acute exercise on undercarboxylated osteocalcin in obese men. Osteoporos Int (2010) 0.91
Cardiac tamponade resulting from non-penetrating chest injury, with reports of two cases. Aust N Z J Surg (1967) 0.90
The CARI guidelines. Assessment of kidney function in type 2 diabetes. Nephrology (Carlton) (2010) 0.90
Alterations in renal degradation of albumin in early experimental diabetes in the rat: a new factor in the mechanism of albuminuria. Clin Sci (Lond) (1998) 0.90
Malignant mesothelioma: a review of 35 cases with diagnosis and prognosis. Pathology (1980) 0.89
Effect of diabetes and aminoguanidine therapy on renal advanced glycation end-product binding. Kidney Int (1999) 0.89
Relative contributions of advanced glycation and nitric oxide synthase inhibition to aminoguanidine-mediated renoprotection in diabetic rats. Diabetologia (1997) 0.89
Salt restriction reduces hyperfiltration, renal enlargement, and albuminuria in experimental diabetes. Diabetes (1997) 0.89
Circulating PTH and PTHrP levels before and after treatment of tumor induced hypercalcemia with Pamidronate Disodium (APD). J Clin Endocrinol Metab (1992) 0.89
Spontaneous paracentesis following rupture of an umbilical hernia. Aust N Z J Surg (1990) 0.89
Diabetic vascular complications. Clin Exp Pharmacol Physiol (1997) 0.88
Differential renal protein clearance in diabetes. Diabetes (1973) 0.88
Fractional clearance of albumin is influenced by its degradation during renal passage. Clin Sci (Lond) (1997) 0.88
The incidence of benign renal nodules (a clinicopathologic study). J Urol (1971) 0.88
Transient early diastolic murmurs in patients with renal failure. Med J Aust (1970) 0.87
Genetic hypertension accelerates nephropathy in the streptozotocin diabetic rat. Am J Hypertens (1988) 0.87
Membranous glomerulonephritis associated with sarcoidosis. Aust N Z J Med (1978) 0.87
Functional erythropoietin deficiency in patients with Type 2 diabetes and anaemia. Diabet Med (2006) 0.87
Use of 5-fluorocytosine in patients with impaired renal function. Br Med J (1973) 0.87
Progression of proteinuria in type 1 and type 2 diabetes. Diabet Med (1988) 0.87
Pathogenesis and intervention strategies in diabetic retinopathy. Clin Experiment Ophthalmol (2001) 0.86
Renal sodium handling and responsiveness of plasma renin levels in hypertension. Clin Sci (1969) 0.86
Anaphylaxis to suxamethonium. A case report. Br J Anaesth (1967) 0.86
Watery diarrhea-hypokalemia-achlorhydria syndrome and carcinoma of the esophagus. Gastroenterology (1985) 0.86
Aminoguanidine ameliorates overexpression of prosclerotic growth factors and collagen deposition in experimental diabetic nephropathy. J Am Soc Nephrol (2001) 0.86
Effects of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatment. Kidney Int (1996) 0.86
Nephropathy in model combining genetic hypertension with experimental diabetes. Enalapril versus hydralazine and metoprolol therapy. Diabetes (1990) 0.85
Aminoguanidine has an anti-atherogenic effect in the cholesterol-fed rabbit. Atherosclerosis (1998) 0.85
Albuminuric and non-albuminuric pathways to renal impairment in diabetes. Minerva Endocrinol (2005) 0.85
Glomerular filtration rate in streptozocin-induced diabetic rats. Role of exchangeable sodium, vasoactive hormones, and insulin therapy. Diabetes (1990) 0.85
Metabolism and blood levels following infusion of a radioactive analog of angiotensin. Am J Physiol (1968) 0.85
Phaeochromocytoma in the elderly: a poorly recognised entity? Br Med J (Clin Res Ed) (1986) 0.85
Clinical applications and complications of umbilical vein cannulation. Br J Surg (1971) 0.84
Effect of early menopause on bone mass in normal women and patients with osteoporosis. Am J Med (1988) 0.84
Localization of secreted protein acidic and rich in cysteine (SPARC) expression in the rat eye. Connect Tissue Res (1999) 0.84
Left ventricular function in uremia: echocardiographic assessment in patients on maintenance dialysis. Clin Nephrol (1981) 0.84
The prolonged use of trimethoprim-sulphonamide in urinary infection. Med J Aust (1973) 0.84
Asbestos bodies in lungs: an Australian report. Pathology (1969) 0.83